SymbolEZRA
NameRELIANCE GLOBAL GROUP, INC.
SectorFINANCE
RegionNorth America
IndustrySpecialty Insurers
Address300 BLVD. OF THE AMERICAS,SUITE 105, LAKEWOOD, New Jersey, 08701, United States
Telephone+1 732 - 380-4600
Fax
Email
Websitehttps://www.relianceglobalgroup.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001812727
Description

Reliance Global Group, Inc. operates as a holding company with diversified interests in the insurance and real estate markets. The Company is focused on acquiring growing, cash flow positive insurance agencies. Within the real estate segment, the Company is involved in acquiring, owning, leasing, managing, and redeveloping multifamily residential properties throughout the U.S. for risk-adjusted returns.

Additional info from NASDAQ:
Reliance Global Group, Inc. operates as a holding company with diversified interests in the insurance and real estate markets. The Company is focused on acquiring growing, cash flow positive insurance agencies. Within the real estate segment, the Company is involved in acquiring, owning, leasing, managing, and redeveloping multifamily residential properties throughout the U.S. for risk-adjusted returns.

2026-05-07 20:08

Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments

Read more
2026-05-07 10:15

(99% Neutral) RELIANCE GLOBAL GROUP, INC. (EZRA) Announces Business Combination

Read more
2026-05-06 15:00

Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Read more
2026-05-05 13:25

Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment

Read more
2026-05-04 20:35

(90% Positive) RELIANCE GLOBAL GROUP, INC. (EZRA) Provides Update on potential for pediatric oncology

Read more
2026-05-04 18:27

New Form DEFA14A - Reliance Global Group, Inc. <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001493152-26-021160 <b>Size:</b> 623 KB

Read more
2026-05-04 12:17

Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division

Read more
2026-04-29 17:06

New Form 424B3 - Reliance Global Group, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001493152-26-019587 <b>Size:</b> 181 KB

Read more
2026-04-29 07:08

New Form EFFECT - Reliance Global Group, Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 9999999995-26-001352 <b>Size:</b> 1 KB

Read more
2026-04-28 13:17

Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones

Read more